What is Cortagen?
Cortagen is a tiny synthetic peptide — just four amino acids strung together (Ala-Glu-Asp-Pro) — that was designed to mimic the signals naturally produced by the brain's outer layer, the cerebral cortex. In the world of peptide science, it belongs to a family sometimes called cytogens or peptide bioregulators: short messenger molecules that tell specific tissues how to behave.[4] Researchers at the St. Petersburg Institute of Bioregulation and Gerontology synthesized Cortagen by analyzing the amino acid make-up of a natural brain extract called Cortexin, then recreating its core signaling sequence in the lab.[4] Because it is a research compound, Cortagen is studied in laboratory and preclinical settings — it is not approved for human medical use and this page is for educational purposes only.
How Cortagen Works
Think of Cortagen like a short text message sent to brain and nerve cells. The message essentially says: "Grow, repair, protect." Because it was built from brain-cortex chemistry, it appears to be recognized preferentially by brain and nerve tissue. In lab culture experiments, Cortagen stimulated the growth of rat brain-cortex tissue explants, while having much weaker effects on other tissue types tested at the same time.[5] This tissue-specific behavior is a hallmark of peptide bioregulators — each short peptide tends to "speak" most loudly to the tissue it was derived from.
At the molecular level, a microarray study looked at how Cortagen changes which genes are switched on or off. Researchers gave mice a five-day course of Cortagen injections, then scanned the activity of over 15,000 gene transcripts in heart tissue. They found 110 known genes with meaningfully altered expression — some turned up, some turned down — suggesting Cortagen influences a broad but specific network of biological pathways.[4] What those exact pathways do in nerve tissue is still an active area of investigation.
One thing researchers have noted is what Cortagen does not do: in immune-cell studies, it did not significantly stimulate thymocyte (immune cell) proliferation or the sphingomyelin signaling pathway the way some other short peptides do.[6] This selectivity hints that Cortagen's primary action is in neural tissue rather than the immune system.
What the Research Shows
Nerve Regeneration
Some of the most striking preclinical findings involve peripheral nerve repair. In one study, rats whose sciatic nerve had been surgically cut and sutured were given intramuscular Cortagen (10 µg/kg) for ten days afterward. The nerve fibers in the Cortagen group grew faster and conducted electrical signals 40% more efficiently than controls.[2] A follow-up paper explored the delayed effects of this treatment — looking at whether benefits persisted long after dosing stopped — and found evidence of lasting functional recovery.[1]
Brain Ischemia (Reduced Blood Flow)
Chronic brain ischemia means the brain isn't getting enough blood — and oxygen — over a long period. In a rodent model of this condition, both Cortagen and the related polypeptide Cortexin helped ischemic rats recover normal behavior more quickly. Just as importantly, both peptides reduced harmful lipid peroxidation (a type of cell damage caused by free radicals) and helped preserve the brain's natural antioxidant defenses.[3] The researchers concluded the findings support exploring these peptides as part of neuroprotective strategies.[3]
Gene Expression in the Heart
Because early human observations suggested Cortagen might affect cardiovascular as well as brain function, scientists used DNA microarray technology to map its effects on cardiac gene activity. Out of more than 15,000 transcripts screened, about 234 showed significant changes after Cortagen treatment — with the largest single gene increase reaching roughly 5.4-fold up-regulation.[4] This cross-tissue finding raises interesting questions about how widely peptide bioregulators ripple through the body.
What Cortagen Is Being Studied For
- Peripheral nerve repair — accelerating regrowth and signal conduction after nerve injury[2]
- Neuroprotection — shielding brain cells from damage caused by chronic low oxygen (ischemia)[3]
- Antioxidant support in the brain — reducing oxidative stress markers during ischemic conditions[3]
- Gene-level effects — understanding which molecular switches Cortagen flips in various tissues[4]
- Tissue-specific bioregulation — mapping how cortex-derived peptides preferentially act on brain versus other tissues[5]
How Cortagen Is Dosed in Research
Preclinical studies have used intramuscular injection protocols, with one key rat study employing 10 µg/kg per day for a 10-day course following nerve injury.[2] However, dosing in research settings varies depending on the model, the outcome being measured, and the species involved. Rather than list every variable here, we've compiled the available research dosing information in the dosage chart on this page. You can also use the interactive calculator to work through weight-based conversions for preclinical reference purposes. Remember: these are research figures only, not clinical dosing guidance.
Mixing and Storing Cortagen
Cortagen, like most research peptides, typically arrives as a lyophilized (freeze-dried) powder in a sealed vial. To reconstitute it, researchers commonly add bacteriostatic water or sterile saline slowly down the side of the vial — never shaking, just gently swirling — until the powder dissolves completely. The resulting solution should be clear. Once reconstituted, it is generally stored in a refrigerator (around 2–8 °C) and used within a few weeks; for longer storage, keeping the unreconstituted powder in a freezer is preferred. Always check the supplier's documentation for specific storage recommendations, and handle all research compounds under appropriate laboratory conditions.
Sources
- The delayed effect of cortagen on the restoration of injured nerve function. — Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2002. PMID 12134478.
- Effect of tetrapeptide cortagen on regeneration of sciatic nerve. — Bulletin of experimental biology and medicine, 2000. PMID 11276314.
- [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]. — Eksperimental'naia i klinicheskaia farmakologiia, 2011. PMID 21476278.
- Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. — Neuro endocrinology letters, 2004. PMID 15159690.
- Tissue-specific effects of peptides. — Bulletin of experimental biology and medicine, 2001. PMID 11713572.
- Effects of short peptides on thymocyte blast transformation and signal transduction along the sphingomyelin pathway. — Bulletin of experimental biology and medicine, 2002. PMID 12420072.
EN
BR
ES
FR
DE
RU